Abstract

To describe baseline neurologic function of symptomatic patients in an international registry for transthyretin amyloidosis (ATTR). The Transthyretin Amyloidosis Outcomes Survey (THAOS) characterizes the natural history of ATTR, regional differences in disease expression, and genotypic-phenotypic relationships. Eligible patients have confirmed genotyped TTR mutations with or without symptomatic disease, or wild-type ATTR. Recommended minimal neurologic evaluations include pinprick, touch, and vibration of the great toe; ankle and patellar reflexes; muscle strength of toes and ankles.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call